Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

14%

1 trials in Phase 3/4

Results Transparency

50%

2 of 4 completed trials have results

Key Signals

2 with results

Enrollment Performance

Analytics

N/A

4(66.7%)

Phase 2

1(16.7%)

Phase 3

1(16.7%)

6Total

N/A(4)

Phase 2(1)

Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT04982874Not ApplicableCompleted

Bioequivalence Study of Furosemide 40 mg Tablet in 24 Indonesian Healthy Volunteers

Role: lead

NCT06066827Not ApplicableUnknown

Hair Regeneration in Androgenetic Alopecia

Role: collaborator

NCT05508191Not ApplicableCompleted

Microneedle Versus Fractional CO₂ Laser for Skin Aging Treatment With Stem Cell Secretome in Indonesian Adult Women

Role: collaborator

NCT04988646Not ApplicableCompleted

Pharmacokinetic Properties of 200 and 400 mg Acyclovir Tablet in Indonesia Healthy Subject

Role: lead

NCT05126550Unknown

The Immunogenicity, Safety, and Effectiveness of the COVID-19 Inactivated Vaccine

Role: lead

NCT05172193Phase 2Unknown

Safety & Immunogenicity of Booster SARS-CoV-2 Vaccine (Vero Cell)

Role: lead

NCT05296863Phase 3Completed

Adipose-derived Stem Cell Conditioned Media as a Novel Approach for Hair Regrowth in Male Androgenetic Alopecia

Role: collaborator

All 7 trials loaded